P.4.d.001 - Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalized anxiety disorder

Saved in:
Bibliographic Details
Published inEuropean neuropsychopharmacology Vol. 27; p. S1003
Main Authors Stein, D.J., Khoo, J.P., Van Ameringen, D.M., Hoschl, C., Ahokas, A., Bauer, M., Bitter, I., Jarema, M., Mosolov, S., Vavrusova, L., Picarel-Blanchot, F., Matharan, S., Olivier, V.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2017
Online AccessGet full text

Cover

More Information
ISSN:0924-977X
1873-7862
DOI:10.1016/S0924-977X(17)31762-5